Tag: pricing

Berkshire residential estate agents competition case

Here’s the latest news involving the Competition and Markets Authority (CMA) investigation into alleged competition infringements involving Berkshire residential estate agents.

The investigation was launched in early 2018 on the basis that the CMA suspected that there may be infringements of important competition law. In June last year, the CMA issued a formal statement of objections to four estate agents with allegations of breaches, and a settlement was reached with two agents in October. More fines were then issued at the end of last year.

In the often-volatile property market, competition law breaches that leave buyers and sellers paying more simply cannot go unpunished.

CMA issue substantial Fender competition breach fine

First published by Author on January 30, 2020 in the following categories: Price Fixing Price Hikes Pricing Selling Restrictions and tagged with cma | competition law | price fixing | pricing

The Competition and Markets Authority (CMA) has issued a substantial Fender competition breach fine in the sum of £4.5m.

The fine has been issued almost two years after an investigation into the prominent guitar maker was opened. In its ruling, the CMA has confirmed that Fender has admitted to breaking competition law by restricting prices for UK retailers. The fine that has been issued is therefore subject to the CMA’s leniency and cooperation protocols, which can see penalties reduced.

This is a key ruling given the size of this growing market and the fact that Fender is one of the major players in the sector.

Provisional finding in drug price hikes case

The UK’s competition regulator has made a provisional finding in the longstanding investigation into drug price hikes, and the outcome is damning.

Issues surrounding pharmaceutical competition breaches are numerous and serious. At the end of the day, the consumer in these cases is patients and the NHS; that’s our tax money.

Any infringement of vital competition laws when it comes to medical matters should always lead to significant punishments, and the work of the CMA (Competition and Markets Authority) in this area is incredibly important. The provisional finding in this matter accompanies an admission from one of the companies involved as well.

More time allowed in the supply of groundworks investigation

First published by Author on November 20, 2019 in the following categories: Industry Market Sharing Price Fixing Pricing and tagged with cma | competition law | construction industry | pricing

More time has been allowed for representations to be made in the supply of groundworks investigation that’s currently being undertaken by the UK’s competition regulator.

The CMA (Compensation and Markets Authority) issued their statement of objections back in April 2019 and announced their provisional findings. The CMA confirmed that they suspect there are three suppliers who are engaging in behaviour that may distort competition in the market. Until final determinations are made, these are just allegations at this stage.

Notably, the CMA decided to continue with their investigations, so we assume that they must believe that there is some evidence to support their allegations.

Most favoured nation clauses in price comparison websites sector

As it has been a while since we looked at this one, here’s the latest in the investigation into alleged most favoured nation clauses in the price comparison website sector.

The investigation that’s being carried out by the Competition and Markets Authority (CMA) is over the alleged use of such clauses for price comparison websites in relation to insurance products. The term “most favoured nation” originates from international trade agreements, whereby more favourable trade terms have been used between countries who favour each other more. In terms of competition law, it’s about contractual provisions whereby a seller may provide their best terms specifically to a particular buyer.

Such behaviour can restrict and distort competition, which is why it’s important for the CMA to look into it.

Precast concrete drainage products supply investigation: latest

The CMA (Competition and Markets Authority) has issued an update in the investigation into the supply of precast concrete drainage products.

The civil investigation has been ongoing since 2016 and a number of actions and steps have been taken in the three years since it was commenced.

This month, an important development has been announced which involves fines in the tens of millions for companies who have reportedly been engaging in cartel behaviour for a number of years.

Hydrocortisone tablets competition investigation

First published by Author on October 09, 2019 in the following categories: Healthcare Market Dominance Abuse and tagged with cma | competition law | investigations | market abuse | pricing

Here’s the latest in the hydrocortisone tablets competition investigation that’s being conducted by the Competition and Markets Authority (CMA).

The history of this key study goes way back to October 2017 when the CMA started looking into alleged anti-competitive agreements and alleged abusive conduct. Exactly two years on, a great deal has happened as the CMA looks to ensure that the NHS and patients alike are not being ripped off by vastly wealthy pharmaceutical companies.

As we often say when the investigation involves the healthcare industry, this is a serious and important matter.

Anti-virus software sector investigation latest

First published by Author on September 12, 2019 in the following categories: Industry Pricing and tagged with cma | competition law | investigations | pricing

Here’s the latest in the important anti-virus software sector investigation that’s being conducted by the CMA (Competition and Markets Authority).

It’s an important one, especially given how prevalent cybersecurity is these days. There have been so many hacks and attacks in recent times that all organisations – both public and private sector – must invest properly to ensure that they’re defended.

But are service providers in the sector offering their vital line of defence in terms that are deemed as fair, and in the spirit of healthy competition? That’s essentially what the CMA wants to find out.

Loyalty penalty investigation: the latest

First published by Author on September 04, 2019 in the following categories: Investigations Loyalty Penalties Pricing and tagged with cma | incentives | investigations | loyalty penalties | pricing

There has been an update about some of the positive steps that have been taken in the wake of the huge loyalty penalty investigation, often referred to as a “super complaint”.

A “super complaint” is a complaint that’s usually submitted by a consumer body on behalf of a number of people who have the same complaint against sometimes several companies, and sometimes across more than one sector. The loyalty penalty super complaint stemmed from the Citizens Advice Bureau who had raised concerns over customers paying more for goods and services for sticking with the same suppliers.

This one has covered notable areas that include insurance, mortgages, bank accounts, broadband services and mobile services.

Anti-competitive agreements for pharmaceutical drugs: statement of objections issued

In the latest investigation into suspected anti-competitive agreements for pharmaceutical drugs, a statement of objections has been issued by the CMA (Competition and Markets Authority).

The statement was issued last month and relates to a number of pharmaceutical companies who stand accused of participating in anti-competitive behaviour. Whether it’s a case of formal agreements in place, or concerted practices, the issue surrounds the supply of 50mg and 100mg nitrofurantoin capsules in the UK.

This investigation by the CMA into the practices of pharmaceutical firms is one of many that have been ongoing for a number of years. They’re one of the most important areas the CMA needs to safeguard.